Authors

Rosenberg, Paul B., Drye, Lea T., Martin, Barbara K., Frangakis, Constantine, Mintzer, Jacobo E., Weintraub, Daniel, Porsteinsson, Anton P., Schneider, Lon S., Rabins, Peter V., Munro, Cynthia A., Meinert, Curtis L., Lyketsos, Constantine G.

Journal

The American Journal Of Geriatric Psychiatry: Official Journal Of The American Association For Geriatric Psychiatry, Volume: 18, No.: 2, Pages.: 136-145

Year of Publication

2010

Abstract

Objective: Depression is common in Alzheimer disease (AD), and antidepressants are commonly used for its treatment, however, evidence for antidepressant efficacy in this population is lacking. The authors conducted a multicenter, randomized, placebo-controlled trial titled “Depression in Alzheimer’s Disease-2” to assess the efficacy and tolerability of sertraline for depression in AD.; Methods: One hundred thirty-one participants from five U.S. medical centers with mild-to-moderate AD (Mini-Mental State Examination scores 10-26) and depression of AD were randomized to double-blinded treatment with sertraline (N = 67) or placebo (N = 64), with a target dosage of 100 mg daily. Efficacy was assessed using logistic regressions and mixed effects models in an intention-to-treat analysis with imputation of missing data. Principal outcome measures were modified Alzheimer’s Disease Cooperative Study-Clinical Global Impression of Change (mADCS-CGIC), change in Cornell Scale for Depression in Dementia (CSDD) scores, and remission defined by both mADCS-CGIC score

Bibtex Citation

@article{Rosenberg_2010, doi = {10.1097/jgp.0b013e3181c796eb}, url = {http://dx.doi.org/10.1097/JGP.0b013e3181c796eb}, year = 2010, month = {feb}, publisher = {Elsevier {BV}}, volume = {18}, number = {2}, pages = {136--145}, author = {Paul B. Rosenberg and Barbara K. Martin and Constantine Frangakis and Jacobo E. Mintzer and Daniel Weintraub and Anton P. Porsteinsson and Lon S. Schneider and Peter V. Rabins and Cynthia A. Munro and Curtis L. Meinert and Constantine G. Lyketsos and Lea T. Drye}, title = {Sertraline for the Treatment of Depression in Alzheimer Disease}, journal = {The American Journal of Geriatric Psychiatry} }